Our approach was to characterize the response of different cancer cell lines using different chemotherapeutic agents and then evaluate the impact of combined chemoradiotherapy on the levels of HIF-1α on the same cells under hypoxia taking the normoxic conditions as reference. This evidence concerns the gene HIF1A and cancer.